Leflunomide as a cause of collagenous colitis: An entity to consider
| dc.coverage | DOI: 10.17235/reed.2021.8015/2021 | |
| dc.creator | Núñez, Paulina | |
| dc.creator | Quera, Rodrigo | |
| dc.creator | Flores, Lilian | |
| dc.creator | Contreras, Luis | |
| dc.date | 2021 | |
| dc.date.accessioned | 2026-01-05T21:20:12Z | |
| dc.date.available | 2026-01-05T21:20:12Z | |
| dc.description | <p>Leflunomide belongs in the group of disease-modifying anti-rheumatic drugs (DMARDs) used in the treatment of psoriatic, rheumatoid, and reactive arthritis. Approximately 20 % of patients will experience some adverse event, mainly weight loss, abdominal pain, and diarrhea. We describe the clinical, endoscopic, and histological findings in a patient with psoriatic arthritis (PA) who developed severe chronic diarrhea after drug use.</p> | eng |
| dc.description | Leflunomide belongs in the group of disease-modifying anti-rheumatic drugs (DMARDs) used in the treatment of psoriatic, rheumatoid, and reactive arthritis. Approximately 20 % of patients will experience some adverse event, mainly weight loss, abdominal pain, and diarrhea. We describe the clinical, endoscopic, and histological findings in a patient with psoriatic arthritis (PA) who developed severe chronic diarrhea after drug use. | spa |
| dc.identifier | https://investigadores.uandes.cl/en/publications/c5b1dfb8-1ab8-4a44-8c83-c3b035a215c0 | |
| dc.identifier.uri | https://repositorio.uandes.cl/handle/uandes/68870 | |
| dc.language | eng | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.source | vol.113 (2021) nr.10 p.735-736 | |
| dc.subject | Chronic diarrhea | |
| dc.subject | Collagenous colitis | |
| dc.subject | Leflunomide | |
| dc.subject | Leflunomide | |
| dc.subject | Collagenous colitis | |
| dc.subject | SDG 3 - Good Health and Well-being | |
| dc.title | Leflunomide as a cause of collagenous colitis: An entity to consider | eng |
| dc.type | Letter | eng |
| dc.type | Carta | spa |